Does OCRELIZUMAB Cause Peripheral swelling? 451 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 451 reports of Peripheral swelling have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.8% of all adverse event reports for OCRELIZUMAB.
451
Reports of Peripheral swelling with OCRELIZUMAB
0.8%
of all OCRELIZUMAB reports
2
Deaths
156
Hospitalizations
How Dangerous Is Peripheral swelling From OCRELIZUMAB?
Of the 451 reports, 2 (0.4%) resulted in death, 156 (34.6%) required hospitalization, and 3 (0.7%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 451 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which OCRELIZUMAB Alternatives Have Lower Peripheral swelling Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE